key: cord-1051781-dt6t7on9 authors: Arain, Savera; Thalapparambath, Rajesh; Al Ghamdi, Fuad Hamed title: COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department date: 2020-05-18 journal: Res Social Adm Pharm DOI: 10.1016/j.sapharm.2020.05.016 sha: b4fafe6eeaa973831f1b0b031abbfe9d68e000a2 doc_id: 1051781 cord_uid: dt6t7on9 The coronavirus disease 2019 (COVID-19) is an ongoing pandemic having caused a major health care crises across the globe.Pharmacy professionals are considered vital in preparation for optimal response to the COVID-19 pandemic. Therefore, in response to the estimated potential impact of COVID-19 on Johns Hopkins Aramco Healthcare (joint venture between Saudi Aramco and Johns Hopkins Medicine International), several initiatives were taken by the hospital's inpatient pharmacy department with focus on infection control, staffing, meeting clinical operational challenges, ethics, increased utilization of automation, and maintenance of employee wellness to prepare for this challenge. The plan implemented by the inpatient pharmacy department was prepared while incorporating information and recommendations from leading pharmacy organizations, ministry of health, institute's experience in battling another similar coronavirus (the Middle East respiratory syndrome–coronavirus) previously, and updated scientific research. The key focus areas include development of an institutionalized COVID-19 protocol, measures to improve infection control when handling and dispensing medications, modified staffing plan, system changes in peri-operative areas, keeping pharmacy professionals updated about new and scientific researches, increased utilization of automation, clinical interventions by pharmacist ensuring appropriate utilization of medications while monitoring for drug-drug interactions, adverse drug event prevention, and preparing for handling drug shortages. By implementing a robust plan, pharmacy professionals continue to show that they are an integral member of inter-professional health care teams. The coronavirus disease 2019 is an ongoing pandemic having caused a major health care crises across the globe.Pharmacy professionals are considered vital in preparation for optimal response to the COVID-19 pandemic. Therefore, in response to the estimated potential impact of COVID-19 on Johns Hopkins Aramco Healthcare (joint venture between Saudi Aramco and Johns Hopkins Medicine International), several initiatives were taken by the hospital's inpatient pharmacy department with focus on infection control, staffing, meeting clinical operational challenges, ethics, increased utilization of automation, and maintenance of employee wellness to prepare for this challenge. The plan implemented by the inpatient pharmacy department was prepared while incorporating information and recommendations from leading pharmacy organizations, ministry of health, institute's experience in battling another similar coronavirus (the Middle East respiratory syndrome-coronavirus) previously, and updated scientific research. The key focus areas include development of an institutionalized COVID-19 protocol, measures to improve infection control when handling and dispensing medications, modified staffing plan, system changes in peri-operative areas, keeping pharmacy professionals updated about new and scientific researches, increased utilization of automation, clinical interventions by pharmacist ensuring appropriate utilization of medications while monitoring for drug-drug interactions, adverse drug event prevention, and preparing for handling drug shortages. By implementing a robust plan, pharmacy professionals continue to show that they are an integral member of inter-professional health care teams. Hopkins Aramco Healthcare keeps safety of visitors, patients, employees, and physicians as its highest priority. Having a 4 realistic staffing and business continuity plan in place would have ensured that the department would function at a high 5 level even in the most challenging times. Also, knowing that "now is the time to act", step-by-step strategies were 6 implemented by the department to ensure that we are able to put our patients first. Being a proud recipient of gold 7 certification for excellence in Person-Centered Care by Planetree International, all of the above measures have been 8 made with an emphasis on our commitment to the culture of person-centered care. Patient-centered approach with the 9 focus on patient care and safety was always kept in mind when introducing new plans or changing our existing care plan. Pharmacists from inpatient pharmacy department provided this care in close coordination as part of multidisciplinary team 11 either through a collaborative practice agreement or as a part of the patient's healthcare team. Development of COVID-19 Protocol: A multidisciplinary expert committee was constituted by the hospital 14 administration to review the available information and protocols on COVID-19. The committee consists of an infectious • The order set shall reduce variation, and unintentional oversight through standardized formatting. • Integrate safety alerts, pertinent reminders, and "best practices" using the clinical decision support 27 system. One example of "best practice" includes justification of use of corticosteroids in COVID-19 28 patients. • Every medication included in the order set was reviewed to ensure appropriate selection of drug, dose, 32 route, and frequency. Clinical Interventions: A variety of valuable clinical interventions were conducted by inpatient pharmacists. These 35 include: • Therapeutic drug monitoring for hydroxychloroquine and lopinavir/ritonavir has been enacted to avoid 37 inappropriate prescribing, and prevent adverse drug events. QT-interval was monitored for patients prescribed 38 hydroxychloroquine by the clinical pharmacist. 5 • The pharmacy issued guidance on the dispensing of hydroxychloroquine upon discharge for the treatment of 40 COVID-19. • Transition from nebulizers to hand-held inhalers for patients requiring inhaled therapy when feasible and safe. 6 • Review of electronic best practice advisory for hydroxychloroquine such as monitoring parameters for baseline 43 and follow up ECG incorporated into the computerized physician order entry system. • Medication adjustment for patients with renal insufficiency being made per institutional policy. • Computerized physician order entry system generated report utilized to review liquid medication preparations, and 51 their rationale for use to avoid wastage. Safety measures for infection control: Several safety measures have been taken to protect both our pharmacy staff 54 and our patients using the interim guidance from governmental and professional pharmacy organizations. Some of the 55 key best practices adopted included: minimum distance of 1.5meters. 9 • Adding floor markings on the ground to section areas of the pharmacy that patients can stand in while waiting or 64 being helped. • Nursing unit inspections being done on regular basis with special emphasis on neuromuscular blockers and 66 emergency medication kits such as 'rapid sequence intubation'kits. • Guidance provided for pharmacists in emergency services pharmacy on socially-distanced methods of patient 68 counseling and prescription handling. 9 • Enable independent double check for high alert medications to be conducted at the automated drug dispensing 70 system in isolation wards instead of patient bedside. • Based on organizational medication administration guideline consolidate dispensing times -e.g., every 12 hours 72 to twice daily, eliminate outlier medication administration times. • For empty narcotic vials in operating rooms and isolated floor automated drug dispensing system, users to ensure 74 wearing gloves and mask before handling and sealing in cartons. 10 75 76 Staffing plan: A temporary department-wide staffing plan has been implemented to adjust to the current situation. The 77 staffing was modified based on both the restrictions imposed by the government and the advice from ministry of health. Given however that our employees are the "backbone" of the department, our remaining colleagues took upon the System changes in Peri-Operative areas: Automated drug dispensing systems were removed from two operating 99 rooms, and cardiac catheterization (cath) labs were reserved to manage COVID-19 patients to avoid contamination. Instead, they were supplied isolation kits with medications. In the event, the hospital reaches full capacity for COVID-19 101 patients, two new "clean areas" in post anesthesia care unit and outpatient procedure area have been created. Automated 102 drug dispensing system has been already mapped to serve these new areas. Communication:The pharmacy department is ensuring that relevant information about inpatient pharmacy updates is 105 communicated to the employees, colleagues from other departments as well as our valued patients. Pharmacy employees 106 received emails about preparedness, schedule changes, workplace mitigation strategies, and Johns Hopkins Aramco 107 healthcare and ministry of health COVID-19 updates. Also, webinars and resources are available to seek more 108 information.Given rapidly evolving data on COVID-19, a weekly update series prepared by an inpatient pharmacist is 109 being shared as internal circular to increase awareness amongst staff about recent scientific and research updates. 85% of the medication dispensing for the majority of patient areas are fulfilled by the automated drug dispensing system. Following the announcement from the organization about the pandemic, a decision was made to maximize the capacity of 127 automated drug dispensing systems, especially for the isolation areas and intensive care units. A periodic review of cart-128 fill medications was scheduled with pharmacy automation team. This strategy helped us to minimize the visit to those 129 areas where isolation precautions are strictly enforced. Cart-fill medications are being perpetually reviewed, utilizing system-generated reports. Based on the findings of the 131 report, more medications were added to the automated drug dispensing system and par levels (days of stock) were 132 increased to reduce the frequency of restocking and thereby reduce traffic to the central pharmacy. 9 In the central 133 pharmacy, a container of the appropriate cleaning disinfectant was placed nearby to allow those accessing the automated 134 drug dispensing system to disinfect common touch points. 15 The system in place already does not allow medications removed from the automated drug dispensing system to be 136 returned to the specific bin or pocket from which they were removed. This was reinforced to minimize the risk of errors 137 and cross-contamination. A designated return bin for medication is used for returning un-administered medications to the 138 pharmacy, as long as they have not entered an isolation patient's room. During the refilling process, pharmacy staff disinfected the automated drug dispensing system and barcode scanners 140 while wearing appropriate personal protective equipment (PPE Accessed 188 Date 5 th April 2020 189 14-Guidance on adaptations to standard UK critical care medication prescribing and administration practices during 190 pandemic emergency pressures We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed.We further confirm that the order of authors listed in the manuscript has been approved by all of us. We understand that the corresponding author is the sole contact for the Editorial process. She is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere.